CONMED Corporation Adds Two Health Care Executives to its Board of Directors
July 01 2015 - 8:00AM
Business Wire
CONMED Corporation (NASDAQ: CNMD) today announced that it
has added David Bronson and John L. Workman to its Board of
Directors, effective immediately.
“David and John are outstanding additions to our Board,”
commented Mark Tryniski, Chairman of CONMED’s Board of Directors.
“They both have extensive experience leading sophisticated health
care organizations, executing successful turnarounds, and improving
shareholder returns. Their impressive track records will make them
vital contributors in guiding CONMED’s growth strategy.”
“We are thrilled to welcome David and John to our Board of
Directors,” said Curt R. Hartman, President and Chief Executive
Officer of CONMED. “These health care industry veterans bring
proven executive leadership and financial expertise, and we are
confident that they will provide valuable counsel as we continue to
enhance our growth opportunities for the benefit of our customers,
shareholders, and employees.”
Mr. Bronson served as Executive Vice President and Chief
Financial Officer of PSS World Medical, Inc. from 2002 until
it was acquired by McKesson Corp in 2013. In that role, he
developed and executed strategies to improve profitability and
returns on capital, and he led the deal process, due diligence, and
pre-close integration efforts for the acquisition of PSS by
McKesson. Prior to that, he was Chief Financial Officer of
Digineer, Inc. from 2001 to 2002 and of VWR Scientific Products
from 1995 to 1999, when it was acquired by Merck KGaA. Mr. Bronson
previously spent 15 years at Baxter Healthcare, Inc., where he held
various senior financial executive positions. He is currently a
Director and Audit Committee Chair of AxelaCare, Inc. and a
Director and a member of the Audit Committee of Labsco, Inc.
Mr. Bronson received his Master of Science Degree in Management
Studies from Northwestern University’s Kellogg School of Business
and his Bachelor of Science Degree in Accounting from California
State University, Fullerton.
Mr. Workman served as Chief Executive Officer of Omnicare, Inc.
from 2012 to 2014, as President and Chief Financial Officer from
2011 to 2012, and as Executive Vice President and Chief Financial
Officer from 2009 to 2010. At Omnicare, he improved operating
efficiencies through a focus on customer service and returned the
company to growth and stability. From 2004 to 2009, he was Chief
Financial Officer of HealthSouth Corporation, where he oversaw the
most comprehensive financial statement reconstruction in Corporate
America and reduced the company’s debt level by 50% through both a
recapitalization and asset divestitures. Prior to HealthSouth, Mr.
Workman served as Chief Executive Officer of U.S. Can Corporation,
where he implemented successful cost reduction and lean
manufacturing programs and led a turnaround of the company’s
European operations. Mr. Workman started his distinguished career
at KPMG, where he was a partner from 1981 to 1984. He is currently
Chairman of the Board and Audit Committee Chair of Universal
Hospital Services and a Director and Audit Committee Chair of
Federal Signal Corp.
Mr. Workman received his Master of Business Administration in
Finance and Accounting from the University of Chicago and his
Bachelor of Science Degree in Accounting from Indiana
University.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery and gastroenterology. The Company distributes its
products worldwide from several manufacturing locations. CONMED has
a direct selling presence in 16 countries outside the United
States, and international sales constitute over 50% of the
Company’s total sales. Headquartered in Utica, New York, the
Company employs 3,400 people. For more information, visit
www.conmed.com.
Forward Looking Information
This press release contains forward-looking statements based on
certain assumptions and contingencies that involve risks and
uncertainties. The forward-looking statements are made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 and relate to the Company's performance on a
going-forward basis. The forward-looking statements in this press
release involve risks and uncertainties, which could cause actual
results, performance or trends, to differ materially from those
expressed in the forward-looking statements herein or in previous
disclosures. In addition to general industry and economic
conditions, factors that could cause actual results to differ
materially from those discussed in the forward-looking statements
in this press release include, but are not limited to the risks
relating to forward-looking statements discussed in the Company's
Annual Report on Form 10-K for the fiscal year ended December 31,
2014.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150701005294/en/
CONMED CorporationLuke Pomilio,
315-624-3202Chief Financial Officer
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Apr 2024 to May 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From May 2023 to May 2024